Quest Laboratories Ltd

Quest Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 01 September 2026, providing investors with the latest insights into its performance and outlook.

Quest Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 August 2026, providing investors with the latest insights into its performance and outlook.

Quest Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 August 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.

Quest Laboratories Ltd is rated 'Sell' by MarketsMOJO. This rating was last updated on 01 Jul 2026, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed below are current as of 28 July 2026, providing investors with the latest perspective on the company’s position.

Quest Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has recently formed a Death Cross, a significant technical indicator where the 50-day moving average crosses below the 200-day moving average. This development signals a potential deterioration in the stock’s trend and raises concerns about long-term weakness amid an already challenging market environment.

Quest Laboratories Ltd is rated Sell by MarketsMOJO. This rating was last updated on 01 July 2026, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed here are current as of 17 July 2026, providing investors with the latest perspective on the company’s position.

Quest Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 06 July 2026, providing investors with the latest insights into the company’s performance and outlook.

Quest Laboratories Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 30 May 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 24 June 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Quest Laboratories Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 30 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 12 June 2026, providing investors with the most up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Quest Laboratories Ltd has recently experienced a downgrade in its quality grade from good to average, reflecting shifts in its core business fundamentals. This article analyses the key financial metrics, including return on equity (ROE), return on capital employed (ROCE), debt levels, and growth consistency, to understand the factors behind this change and its implications for investors.

Quest Laboratories Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 30 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 31 May 2026, providing investors with the latest insights into the company’s performance and outlook.

Quest Laboratories Ltd., a micro-cap pharmaceutical company with a market capitalisation of ₹190.00 crores, reported a mixed performance in Q4 FY26, with net profit standing at ₹2.87 crores—a decline of 28.78% quarter-on-quarter and 47.94% year-on-year. Whilst revenue showed modest sequential growth of 5.85%, reaching ₹32.40 crores, the company faced significant margin compression that raised concerns about operational efficiency and profitability sustainability.

Quest Laboratories Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 11 May 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 19 May 2026, providing investors with the most up-to-date insight into the company’s performance and outlook.

At Rs 103.90, sellers were still queuing — but there were no buyers willing to take the other side. Quest Laboratories Ltd locked at its lower circuit of 4.98% on 19 May 2026, with unfilled sell orders and a frozen price, reflecting persistent selling pressure in a micro-cap stock with limited liquidity.

At Rs 110.00, sellers were still queuing — but there were no buyers willing to take the other side. Quest Laboratories Ltd locked at its lower circuit of 5% on 18 May 2026, with unfilled sell orders and a frozen price, signalling persistent selling pressure in a micro-cap stock with limited liquidity.

At Rs 116.05, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Quest Laboratories Ltd locked at its upper circuit of 4.98% on 15 May 2026, with buyers queuing and no sellers willing to part with shares.

At Rs 110.00, Quest Laboratories Ltd locked at its lower circuit on 14 Jun 2026, reflecting a 4.92% decline within a 5% price band. Sellers were lined up to exit, but no buyers emerged to absorb the supply, resulting in a frozen price and unfilled sell orders.

At Rs 119.0, sellers were still queuing — but there were no buyers willing to take the other side. Quest Laboratories Ltd locked at its lower circuit of 3.57% on 12 May 2026, with unfilled sell orders and a frozen price.